or
Bookmark and Share
Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
 
   
Document Number
US Patent 7229987
Issued Date
June 12, 2007
Link
Map
Abstract
The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
9
Comments:
no comments yet
Owner
Eli Lilly and Company (Indianapolis, IN)
Published
June 12, 2007
Application Number
10/512,986
Filed
May 6, 2003
US Classification
514/217.1   514/227.8 514/236.8 514/326 514/374 514/378 540/603 544/137 544/60 546/208 548/235 548/247
Int'l Classification
A61K   31/5355   (20060101)   A61K   31/454   (20060101)   C07D   263/32   (20060101)   C07D   401/12   (20060101)   C07D   403/12   (20060101)  
Examiner
Assistant Examiner
Attorney/Law Firm
Parent Case
This is National filing under 35 U.S.C. .sctn. 371 of PCT/US03/1213, filed May 6, 2003, which claims priority from U.S. Provisional Application No. 60/380,351, filed May 13, 2002.
USPTO Field of Search
540/603  
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us
© 2009 - WikiPatents, Inc.
Not affiliated with Wikipedia.